27 related articles for article (PubMed ID: 3560156)
1. Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands.
Juncosa JI; Hansen M; Bonner LA; Cueva JP; Maglathlin R; McCorvy JD; Marona-Lewicka D; Lill MA; Nichols DE
ACS Chem Neurosci; 2013 Jan; 4(1):96-109. PubMed ID: 23336049
[TBL] [Abstract][Full Text] [Related]
2. Proceedings of the British Pharmacological Society. Ireland, 6th-8th July, 1988. Abstracts.
Br J Pharmacol; 1988 Oct; 95 Suppl(Suppl):475P-714P. PubMed ID: 3167315
[No Abstract] [Full Text] [Related]
3. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
[TBL] [Abstract][Full Text] [Related]
4. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
Hacksell U; Johansson AM; Arvidsson L; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Sanchez D; Lindberg P
J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102
[TBL] [Abstract][Full Text] [Related]
5. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
Svensson K; Carlsson A; Johansson AM; Arvidsson LE; Nilsson JL
J Neural Transm; 1986; 65(1):29-38. PubMed ID: 3958706
[TBL] [Abstract][Full Text] [Related]
6. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
Arvidsson LE; Hacksell U; Johansson AM; Nilsson JL; Lindberg P; Sanchez D; Wikström H; Svensson K; Hjorth S; Carlsson A
J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888
[TBL] [Abstract][Full Text] [Related]
7. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
Björk L; Höök BB; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
[TBL] [Abstract][Full Text] [Related]
8. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.
Clark D; Hjorth S; Carlsson A
J Neural Transm; 1985; 62(3-4):171-207. PubMed ID: 2863323
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.
Clark D; Hjorth S; Carlsson A
J Neural Transm; 1985; 62(1-2):1-52. PubMed ID: 3894582
[TBL] [Abstract][Full Text] [Related]
11. Multiple dopamine receptors and behavior.
Joyce JN
Neurosci Biobehav Rev; 1983; 7(2):227-56. PubMed ID: 6136014
[TBL] [Abstract][Full Text] [Related]
12. Microbehavioral methods for measuring the motor and associative effects of dopamine receptor antagonists and related drugs in rodents.
Fowler SC
Psychopharmacology (Berl); 1999 Nov; 147(1):8-10. PubMed ID: 10591856
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
